TABLE 1.
1. Documentation of airflow obstruction | |
| |
Preferred | Documented wheezing and other signs of airflow obstruction by physician or trained health care practitioner |
Alternative | Convincing parental report of wheezing or other symptoms of airflow obstruction |
| |
2. Documentation of reversibility of airflow obstruction | |
| |
Preferred | Documented improvement in signs of airflow obstruction to SABA ± oral corticosteroids* by physician or trained health care practitioner |
Alternative† | Convincing parental report of symptomatic response to a 3-month trial of a medium dose of ICS (with as-needed SABA)* |
Alternative‡ | Convincing parental report of symptomatic response to SABA |
| |
3. No clinical evidence of an alternative diagnosis |
See Table 3 for further details regarding the recommended therapy or therapeutic trial;
In children with frequent symptoms and/or one or more exacerbation requiring rescue oral corticosteroids or a hospital admission;
In children with mild intermittent symptoms and exacerbations, the diagnosis is only suggested because the accuracy of parental report of a short-term response to inhaled short-acting β2-agonists (SABA) may be unreliable due to misperception and spontaneous improvement of another condition. Because this is a weaker alternative diagnostic method, confirmation by direct observation when symptomatic is preferred. ICS Inhaled corticosteroids